The facility, which is located near many customers and major transportation hubs, is also one of the largest sites in Catalent’s global clinical supply network
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has completed a $5.5 million expansion programme at its 200,000+ square foot Philadelphia (PA, USA) site to provide additional clinical packaging and storage capacity.
The investment has provided the site with a 40% increase in pallet space for both refrigerated and ambient clinical storage, additional cold chain packaging areas, and a new clinical label control area.
The building also features a new campus-wide environmental monitoring and building management system.
“The expansion not only allows us to meet the demand for additional capacity to serve large-scale clinical studies today, but also provides the space necessary for future growth,” said Albert Quintero, General Manager, Clinical Supply Services.
He added: “We look forward to welcoming new and existing customers at these new facilities.”
With sites in the US, UK, Germany, Japan and China, and an extended network of more than 50 depots, Catalent’s clinical supply services team has the capability and expertise to handle a broad range of international compliance and distribution requirements, and so help to expedite clinical trials by ensuring customers are reliably supplied where and when needed around the globe.